Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 84%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,428
Total Claims
$2.7M
Drug Cost
984
Beneficiaries
$2,759
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-48%
Opioid rate vs peers
1.3% vs 2.6% avg
+158%
Cost per patient vs peers
$2,759 vs $1,068 avg
+35%
Brand preference vs peers
12.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.3%
Opioid Rate
262
Opioid Claims
$2,204
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,338 claims · $2.3M
Generic: 16,946 claims · $438K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 238 | $393K |
| Semaglutide | 211 | $327K |
| Apixaban | 137 | $141K |
| Fluticasone/Umeclidin/Vilanter | 116 | $132K |
| Empagliflozin | 74 | $127K |
| Tirzepatide | 89 | $125K |
| Sitagliptin Phosphate | 77 | $93K |
| Insulin Glargine,hum.Rec.Anlog | 58 | $79K |
| Rivaroxaban | 64 | $72K |
| Dapagliflozin Propanediol | 56 | $69K |
| Insulin Detemir | 31 | $49K |
| Linaclotide | 40 | $47K |
| Fluticasone/Vilanterol | 39 | $40K |
| Mirabegron | 27 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 28 | $32K |
Prescribing Profile
Patient Profile
70
Avg Age
60%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About